Tirzepatide, a recently approved medication, is showing significant promise as a potential treatment for individuals diagnosed with type 2 diabetes . Unlike existing diabetes drugs , it operates through a dual mechanism, stimulating both the GLP-1 receptor and GIP receptors. Clinical data have demonstrated that tirzepatide can substantially lower g